Article info

Download PDFPDF
CETP inhibition improves the lipid profile but has no effect on clinical cardiovascular outcomes in high-risk patients

Authors

  1. Correspondence to Professor Robert S Rosenson, Cardiometabolics Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Hospital Box 1031, New York, NY 10029, USA; robert.rosenson{at}mssm.edu
View Full Text

Citation

Rosenson RS
CETP inhibition improves the lipid profile but has no effect on clinical cardiovascular outcomes in high-risk patients

Publication history

  • First published August 26, 2017.
Online issue publication 
October 04, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.